SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Acer Therapeutics Inc. – ‘8-K/A’ for 9/19/17

On:  Tuesday, 11/14/17, at 5:22pm ET   ·   For:  9/19/17   ·   Accession #:  1654954-17-10671   ·   File #:  1-33004

Previous ‘8-K’:  ‘8-K’ on / for 11/13/17   ·   Next:  ‘8-K’ on / for 12/11/17   ·   Latest:  ‘8-K’ on 11/20/23 for 11/17/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/14/17  Acer Therapeutics Inc.            8-K/A:9     9/19/17    3:369K                                   Blueprint/FA

Amendment to Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K/A       Amendment to Current Report                         HTML     29K 
 2: EX-99.2     Unaudited Condensed Consolidated Balance Sheet and  HTML    102K 
                          Statement of Income of Private Acer for                
                          the Nine Months Ended September 30, 2017               
 3: EX-99.3     Unaudited Pro Forma Condensed Combined Statement    HTML     27K 
                          of Income of Acer and Private Acer for                 
                          the Nine Months Ended September 30, 2017               




        
Filing Submission 0001654954-17-010671 – SGML Text

Original SGML Text submitted by:  Blueprint/FA  (as Filing Agent) 

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 9:04:18.1am ET